Skip to Content
Not all colorectal cancer treatments are the same. Find out more >

Florbetapir F 18 Pregnancy and Breastfeeding Warnings

Florbetapir F 18 is also known as: Amyvid

Florbetapir F 18 Pregnancy Warnings

Animal reproduction studies have not been conducted. There are no controlled data in human pregnancy. All radiopharmaceuticals, including Florbetapir F-18, can potentially cause fetal harm. The likelihood of fetal harm depends on the stage of fetal development and the radiopharmaceutical dose. Pregnancy status should be assessed before administering this drug to a female of childbearing potential. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if clearly needed. US FDA pregnancy category: C

See references

Florbetapir F 18 Breastfeeding Warnings

A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown Excreted into animal milk: Data not available Comments: The effects in the nursing infant are unknown.

If breastfeeding is discontinued, the patient should pump and discard her breast milk and use alternate infant nutrition sources (e.g., stored breast milk or infant formula) for 24 hours after administration of the drug.

See references

References for pregnancy information

  1. "Product Information. Amyvid (florbetapir F 18)." Lilly, Eli and Company, Indianapolis, IN.

References for breastfeeding information

  1. "Product Information. Amyvid (florbetapir F 18)." Lilly, Eli and Company, Indianapolis, IN.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide